Fortis Healthcare has approved the acquisition of a 31.52% stake held by private equity investors in its subsidiary, Agilus Diagnostics Limited, increasing its ownership from 57.68% to 89.20% and plans to raise funds through Non-Convertible Debentures for this purpose.